Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Covington
US Department of Justice
Merck
Dow
Chinese Patent Office
Baxter
Farmers Insurance
Teva

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070301

« Back to Dashboard

NDA 070301 describes PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, which is a drug marketed by Actavis Elizabeth, Ani Pharms Inc, Ivax Sub Teva Pharms, Mylan, Warner Chilcott, Watson Labs, and Yaopharma Co Ltd, and is included in seventeen NDAs. It is available from one supplier. Additional details are available on the PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE profile page.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.
Summary for 070301

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength25MG;40MG
Approval Date:Apr 18, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Mallinckrodt
Cerilliant
Deloitte
Fuji
QuintilesIMS
Teva
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.